Close

Shire's (SHPG) Vyvanse sNDA Accepted for Review by FDA

September 15, 2014 8:03 AM EDT Send to a Friend
Shire plc (Nasdaq: SHPG) announced that the US Food and Drug Administration (FDA) has accepted for filing with priority review ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login